Brazil Next Generation Cancer Diagnostics Market Size & Outlook
Related Markets
Brazil next generation cancer diagnostics market highlights
- The Brazil next generation cancer diagnostics market generated a revenue of USD 826.3 million in 2024 and is expected to reach USD 2,236.3 million by 2033.
- The Brazil market is expected to grow at a CAGR of 11.7% from 2025 to 2033.
- In terms of segment, next generation sequencing was the largest revenue generating technology in 2024.
- Next Generation Sequencing is the most lucrative technology segment registering the fastest growth during the forecast period.
Next generation cancer diagnostics market data book summary
| Market revenue in 2024 | USD 826.3 million |
| Market revenue in 2033 | USD 2,236.3 million |
| Growth rate | 11.7% (CAGR from 2025 to 2033) |
| Largest segment | Next generation sequencing |
| Fastest growing segment | Next Generation Sequencing |
| Historical data | 2021 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Next Generation Sequencing, QPCR & Multiplexing, LOAC & RT-PCR, Protein Microarrays, DNA Microarrays |
| Key market players worldwide | Johnson & Johnson, Illumina Inc, Novartis AG ADR, Roche, Koninklijke Philips NV, Qiagen NV, Agilent Technologies Inc, Abbott Laboratories, Thermo Fisher Scientific Inc, GE HealthCare Technologies Inc Common Stock |
Other key industry trends
- In terms of revenue, Brazil accounted for 5.0% of the global next generation cancer diagnostics market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In Latin America, Brazil next generation cancer diagnostics market is projected to lead the regional market in terms of revenue in 2033.
- Brazil is the fastest growing regional market in Latin America and is projected to reach USD 2,236.3 million by 2033.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Next Generation Cancer Diagnostics Market Scope
Next Generation Cancer Diagnostics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Roche | View profile | 10001+ | Basel, Basel-Stadt, Switzerland, Europe | http://www.roche.com |
| Qiagen NV | View profile | 5900 | Hulsterweg 82, Venlo, LI, Netherlands, 5912 PL | https://www.qiagen.com |
| Agilent Technologies Inc | View profile | 17700 | 5301 Stevens Creek Boulevard, Santa Clara, CA, United States, 95051 | https://www.agilent.com |
| Illumina Inc | View profile | 9300 | 5200 Illumina Way, San Diego, CA, United States, 92122 | https://www.illumina.com |
| Thermo Fisher Scientific Inc | View profile | 122000 | 168 Third Avenue, Waltham, MA, United States, 02451 | https://www.thermofisher.com |
| Koninklijke Philips NV | View profile | 73712 | Philips Center, Amstelplein 2, Amsterdam, Netherlands, 1096 BC | https://www.philips.com |
| Abbott Laboratories | View profile | 114000 | 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 | https://www.abbottinvestor.com |
| GE HealthCare Technologies Inc Common Stock | View profile | 51000 | 500 West Monroe Street, Chicago, IL, United States, 60661 | https://www.gehealthcare.com |
| Novartis AG ADR | View profile | 76057 | Lichtstrasse 35, Basel, Switzerland, 4056 | https://www.novartis.com |
| Johnson & Johnson | View profile | 134400 | One Johnson and Johnson Plaza, New Brunswick, NJ, United States, 08933 | https://www.jnj.com |
Brazil next generation cancer diagnostics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to next generation cancer diagnostics market will help companies and investors design strategic landscapes.
Next generation sequencing was the largest segment with a revenue share of 37.25% in 2024. Horizon Databook has segmented the Brazil next generation cancer diagnostics market based on next generation sequencing, qpcr & multiplexing, loac & rt-pcr, protein microarrays, dna microarrays covering the revenue growth of each sub-segment from 2021 to 2033.
Concentration of more investments for sequencing and data analysis services in the South-eastern region of the country as a consequence of availability of resources is anticipated to propel growth of this region in diagnostics sector.
Additionally, technology boom in Sao Paulo with respect to computer resources and web development is expected to impact the growth in data analysis segment of NGS technology.
The Brazilian population Based Registry (PBCR) with its twenty establishments across the country has analyzed that there were high cancer incidences between 92 to 220 children/adolescents per 100,000, and children between the ages of 1-4 years.
Reasons to subscribe to Brazil next generation cancer diagnostics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Brazil next generation cancer diagnostics market databook
-
Our clientele includes a mix of next generation cancer diagnostics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Brazil next generation cancer diagnostics market , including forecasts for subscribers. This country databook contains high-level insights into Brazil next generation cancer diagnostics market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Partial client list
Brazil Technology - Next Generation Cancer Diagnostics Market size, 2024 - 2033 (US$M)
Brazil Next Generation Cancer Diagnostics Market Outlook Share, 2024 & 2033 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
